EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nanomotor-Assisted Intravesical Chemotherapy for Bladder Tumor Reduction and Suppression of Early Tumor Regrowth

Kristin Fichna, Maria Crespo-Cuadrado, Acsah Konuparamban, Valerio Di Carlo iD, David Esporrín-Ubieto iD, Ines Macías-Tarrío, Oriol Jutglar Soler iD, Shuqin Chen, María Gómez-Martínez, Anna C Bakenecker, Antoni Vilaseca, Jordi Llop iD und 1 weitere

Nano Letters · 06.05.2026 · 26 (17) · 5618-5627

DOI: 10.1021/acs.nanolett.5c05411 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nano Letters, online erschienen am 23.04.2026. Verfasst von Kristin Fichna und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute for Science and Technology (BIST), Baldiri i Reixac 10-12, 08028 Barcelona,…. Hauptthemen laut MEDLINE: Mitomycin, Urinary Bladder Neoplasms, Nanoparticles, Antibiotics, Antineoplastic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanoparticles are widely used in nanomedicine for controlled drug delivery and improved bioavailability. However, their effectiveness is often limited by passive diffusion, especially in confined, fluid-filled environments like the bladder, where rapid drug clearance and uneven distribution reduce therapeutic impact. These challenges contribute to high recurrence in bladder cancer despite intravesical chemotherapy. To address this limitation, we present urease-powered nanomotors (NM) based on mesoporous silica nanoparticles loaded with Mitomycin C (MMC), the standard chemotherapeutic for nonmuscleinvasive bladder cancer. These NM useurea present in urine to induce motion and drug dispersion. In vitro, NM showed 2.3-fold higher uptake in mouse bladder cancer cells than passive nanoparticles and achieved the efficacy of free MMC (577.5 μg/mL) at a 20-fold lower dose (30 μg/mL). In vivo, a single intravesical dose reduced tumor volumes by 83% and prevented early tumor regrowth, demonstrating the potential of NM-based delivery for bladder cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitomycinUrinary Bladder NeoplasmsNanoparticlesAntibiotics, AntineoplasticAnimalsAdministration, IntravesicalMiceCell Line, TumorHumansSilicon DioxideDrug Delivery SystemsNon-Muscle Invasive Bladder NeoplasmsAntineoplastic AgentsFemale

Stichwörter der Autor:innen

Bladder CancerDrug DeliveryIntravesical ChemotherapyMitomycin CNanomotorsNanoparticles

Substanzen

MitomycinSilicon DioxideAntibiotics, AntineoplasticAntineoplastic Agents

Autor:innen und Institutionen

  • Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute for Science and Technology (BIST), Baldiri i Reixac 10-12, 08028 Barcelona, Spain.
  • Doctorate in Biotechnology, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, Avda. Diagonal 643, 08028 Barcelona, Spain.
  • CIC biomaGUNE, Basque Research and Technology Alliance (BRTA), Paseo Miramón 182, 20014 Donostia/San Sebastián, Spain.
  • Departament de Bioquímica i Fisiologia Facultat de Farmácia i CCAA, Universitat de Barcelona, Av. Joan XXIII, 27-31, 08028 Barcelona, Spain.
  • Department of Urology, Hospital Clinic of Barcelona, 08036 Barcelona, Spain.
  • Catalan Institution for Research and Advanced Studies (ICREA), Passeig Lluís Companys 23, 08010 Barcelona, Spain.

ORCID-Profile: Valerio Di Carlo, David Esporrín-Ubieto, Oriol Jutglar Soler, Jordi Llop, Samuel Sánchez

Zitieren

APA

Fichna, K., Crespo-Cuadrado, M., Konuparamban, A., Di Carlo, V., Esporrín-Ubieto, D., Macías-Tarrío, I., Jutglar Soler, O., Chen, S., Gómez-Martínez, M., Bakenecker, A. C., Vilaseca, A., Llop, J., & Sánchez, S. (2026). Nanomotor-Assisted Intravesical Chemotherapy for Bladder Tumor Reduction and Suppression of Early Tumor Regrowth. Nano Letters, 26(17), 5618-5627. https://doi.org/10.1021/acs.nanolett.5c05411

Vancouver

Fichna K, Crespo-Cuadrado M, Konuparamban A, Di Carlo V, Esporrín-Ubieto D, Macías-Tarrío I, et al. Nanomotor-Assisted Intravesical Chemotherapy for Bladder Tumor Reduction and Suppression of Early Tumor Regrowth. Nano Letters. 2026;26(17):5618-5627. doi:10.1021/acs.nanolett.5c05411

BibTeX
@article{Fichna2026,
  author = {Fichna, Kristin and Crespo-Cuadrado, Maria and Konuparamban, Acsah and Di Carlo, Valerio and Esporrín-Ubieto, David and Macías-Tarrío, Ines and Jutglar Soler, Oriol and Chen, Shuqin and Gómez-Martínez, María and Bakenecker, Anna C and Vilaseca, Antoni and Llop, Jordi and Sánchez, Samuel},
  title = {Nanomotor-Assisted Intravesical Chemotherapy for Bladder Tumor Reduction and Suppression of Early Tumor Regrowth},
  journal = {Nano Letters},
  year = {2026},
  volume = {26},
  number = {17},
  pages = {5618--5627},
  doi = {10.1021/acs.nanolett.5c05411}
}
Kostenlos starten →